Showing results (641-650 of 651) with videos related to
Sort By:
Pageof 66
Nature Cancer|April 3, 2026
Single-cell and spatial profiling in cancer biology and clinical oncologyChris J Frangieh, Joy Linyue Fan, Johannes C Melms, et al.Nature Cancer|April 22, 2026
DeepFAN, a transformer-based model for human-artificial intelligence collaborative assessment of incidental pulmonary nodules in CT scans: a multireader, multicase trialZhenchen Zhu, Ge Hu, Weixiong Tan, et al.Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.Nature Cancer|May 20, 2026
Coupling dead cell recognition to Fcγ receptors augments anticancer immunityTomás Castro-Dopico, Cécile Piot, Michael D Buck, et al.Nature Cancer|May 12, 2026
Harnessing myeloid cell plasticity for cancer therapyEmilio Sanseviero, Simon T Barry, Dmitry I GabrilovichNature Cancer|June 10, 2026
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypesDarui Jin, Artem Shmatko, Areeba Patel, et al.Nature Cancer|June 10, 2026
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacyDelin Kong, Tingting Yang, Mengyu Zhao, et al.Nature Cancer|March 19, 2021
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K Mehta, Emily M Cheney, Christina A Hartl, et al.Nature Cancer|January 10, 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaXiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, et al.Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.Pageof 66